description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ACAATGTTCCGCCCCAAACACTGTGACACGTATTCGGGATGAAAGTATAATAGTCATTCCTTCAACCCTTGCATTTATGGACTCTGGAAATCGAAGATCCACAGTGAGTAAAGATGTTCGTCCAAAGACAAAAAATAGAAACAGCTCAACAAAGCGAGAGACAAAAAAACAAAATGGCACTGTGGCTCTGCCTTTGAAGTCTGGGCTCCAGCAGAGGGCTGATCTTCCCACAGGAGACGAGACGGCCTATGACACTCTCCAGAACTGTTGTCAGTGCCGAATTTTACTTCCCTTGCCCATTCTAAATGAGC
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... XAF1(327959), Xaf1(327959)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Yun-feng Lou et al.
PloS one, 9(5), e97719-e97719 (2014-05-31)
Despite recent advances in the treatment of human colon cancer, the chemotherapy efficacy against colon cancer is still unsatisfactory. In the present study, effects of concomitant inhibition of the epidermal growth factor receptor (EGFR) and DNA methyltransferase were examined in
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU187651-20UG | 04061828744152 |
| EMU187651-50UG | 04061828693207 |